Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type XI alpha 2 pseudogene 1 (COL11A2P1) is a genomic DNA sequence with homology to the gene encoding the alpha-2 chain of type XI collagen (COL11A2), but it is a pseudogene, meaning it does not code for a functional protein and is not expressed as a receptor, enzyme, or structural component[5]. The functional gene *COL11A2* (collagen type XI alpha 2 chain) is responsible for encoding a minor fibrillar collagen crucial for cartilage and connective tissue integrity and, when mutated, is linked to conditions such as Stickler syndrome, otospondylomegaepiphyseal dysplasia, and hearing loss[1][2][3][4]. However, COL11A2P1 itself is not functional, not associated with therapeutic targeting, and not implicated in disease biology or pharmacology[5]. Its only relevance is as a genomic locus used in research to clarify the context or annotation of the functional *COL11A2* gene. Key points regarding inaccuracy or confusion: - COL11A2P1 is sometimes confused with *COL11A2*, the active gene coding for a collagen alpha chain crucial in connective tissue[1][2][3][4]. - COL11A2P1 is a pseudogene—by definition, not a molecular target. There are no drugs or mechanisms associated with this locus, nor disease links, nor molecular function or classification as receptor, enzyme, or other actionable protein[5]. If you were seeking a molecular target with real biological or pharmacological significance, you likely intended *Collagen type XI alpha 2 chain* (*COL11A2*), not the pseudogene *COL11A2P1*.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type XI alpha 2 pseudogene 1 (COL11A2P1).